Insights for How Canada’s Drug Agency Can Evolve Clinician Group Input Submission to Drug Reimbursement Reviews 

Current state: Open 
Feedback period: July 22, 2025, to September 15, 2025 

Clinician input is vital to the work we do at Canada’s Drug Agency (CDA-AMC). The valuable insights and perspectives that clinician groups provide through their input to our drug reimbursement review process help to inform our assessments of the clinical and economic evidence and the deliberations of our expert committees.

Purpose of Feedback

We are inviting interested clinician groups and individual clinicians to provide their insights to inform how we evolve clinician group input submissions to the drug reimbursement reviews process.  

We are seeking feedback on how to best evolve clinician group input to better: 

  • improve ease of clinician input submissions for clinician groups, including clarifying processes and requirements and reducing effort and resources required 
  • increase transparency of how clinician group input is used during expert committee deliberations 
  • align and focus input on what is needed from clinician groups to support deliberations. 

How to Participate

We are inviting representatives from clinician groups and individual clinicians to contribute feedback and ideas in 1 of 2 ways: 

  1. through small group discussion  
  2. in writing via online submission. 

We encourage participants to review the Clinician Group Input – Background Reading in preparation for engagement activities.

Small Group Discussions

During small group discussions, our team will present an overview of how clinician perspectives support the drug reimbursement review process, including expert committee deliberations. We will also share our goals to enhance this process and facilitate a discussion where participants can share their perspectives and suggestions.  

Use the Small Group Registration Form to register and submit your availability for 1 of the 5 sessions:  

  • July 24, 2025, at 12:00 p.m. ET 
  • August 7, 2025, at 6:00 p.m. ET 
  • August 14, 2025, at 3:00 p.m. ET
  • August 19, 2025, at 11:00 a.m. ET 
  • September 9, 2025, at 6:00 p.m. ET 

To ensure we can engage with a diverse range of perspectives, we kindly ask that each clinician group designate only 1 representative to attend. This will help us include as many perspectives as possible in our discussions. 

Written Comments 

Please fill out the Feedback on Evolving Clinician Group Input Form to provide written comments. Feedback must be received by 5:00 p.m. ET on September 15, 2025. For feedback to be considered, individuals and organizations must be identified by name. One response per organization will be considered.  

If you are interested in being involved in this process, but unable to attend a small group discussion session or provide written feedback, please contact us at [email protected]to discuss alternate ways to share your insights. 

Feedback on Evolving Clinician Group Input Form